Takeda Pharmaceutical Company Limited (TAK)
USD 13.11
(-1.87%)
USD 13.11
(-1.87%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 15108.79 Billion JPY | 8.25% |
| 2023 | 13957.75 Billion JPY | 5.92% |
| 2022 | 13178.01 Billion JPY | 2.06% |
| 2021 | 12912.29 Billion JPY | 0.71% |
| 2020 | 12821.09 Billion JPY | -7.58% |
| 2019 | 13872.32 Billion JPY | 237.82% |
| 2018 | 4106.46 Billion JPY | -5.72% |
| 2017 | 4355.78 Billion JPY | 13.9% |
| 2016 | 3824.08 Billion JPY | -10.99% |
| 2015 | 4296.19 Billion JPY | -5.97% |
| 2014 | 4569.14 Billion JPY | 15.51% |
| 2013 | 3955.59 Billion JPY | 10.58% |
| 2012 | 3577.03 Billion JPY | 28.37% |
| 2011 | 2786.4 Billion JPY | -1.31% |
| 2010 | 2823.27 Billion JPY | 2.29% |
| 2009 | 2760.18 Billion JPY | -3.13% |
| 2008 | 2849.27 Billion JPY | -7.27% |
| 2007 | 3072.5 Billion JPY | 0.99% |
| 2006 | 3042.29 Billion JPY | 19.52% |
| 2005 | 2545.43 Billion JPY | 8.98% |
| 2004 | 2335.66 Billion JPY | 13.42% |
| 2003 | 2059.36 Billion JPY | 4.79% |
| 2002 | 1965.21 Billion JPY | 12.44% |
| 2001 | 1747.77 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 15108.79 Billion JPY | 8.25% |
| 2024 Q4 | 15108.79 Billion JPY | 6.23% |
| 2024 Q3 | 14222.94 Billion JPY | -4.36% |
| 2024 Q1 | 14792.73 Billion JPY | 7.41% |
| 2024 Q2 | 14871.88 Billion JPY | -10.2% |
| 2023 Q3 | 13504.7 Billion JPY | -7.43% |
| 2023 Q2 | 14588.84 Billion JPY | 3.72% |
| 2023 FY | 13957.75 Billion JPY | 5.92% |
| 2023 Q1 | 14065.42 Billion JPY | 6.73% |
| 2023 Q4 | 13957.75 Billion JPY | 3.35% |
| 2022 Q3 | 12698.51 Billion JPY | 1.1% |
| 2022 Q1 | 12657.23 Billion JPY | -1.98% |
| 2022 Q2 | 12560.27 Billion JPY | -0.77% |
| 2022 FY | 13178.01 Billion JPY | 2.06% |
| 2022 Q4 | 13178.01 Billion JPY | 3.78% |
| 2021 Q1 | 12613.85 Billion JPY | -1.62% |
| 2021 FY | 12912.29 Billion JPY | 0.71% |
| 2021 Q2 | 12414.74 Billion JPY | -1.58% |
| 2021 Q4 | 12912.29 Billion JPY | 5.1% |
| 2021 Q3 | 12286.13 Billion JPY | -1.04% |
| 2020 Q2 | 12880.14 Billion JPY | -4.95% |
| 2020 Q1 | 13550.42 Billion JPY | -2.32% |
| 2020 Q3 | 13031.49 Billion JPY | 1.18% |
| 2020 Q4 | 12821.09 Billion JPY | -1.61% |
| 2020 FY | 12821.09 Billion JPY | -7.58% |
| 2019 Q4 | 13872.32 Billion JPY | 140.54% |
| 2019 Q2 | 4274.83 Billion JPY | 2.77% |
| 2019 Q1 | 4159.57 Billion JPY | 1.29% |
| 2019 FY | 13872.32 Billion JPY | 237.82% |
| 2019 Q3 | 5767.22 Billion JPY | 34.91% |
| 2018 Q4 | 4106.46 Billion JPY | -6.89% |
| 2018 FY | 4106.46 Billion JPY | -5.72% |
| 2018 Q3 | 4410.55 Billion JPY | 0.79% |
| 2018 Q2 | 4375.95 Billion JPY | 0.69% |
| 2018 Q1 | 4345.92 Billion JPY | -0.23% |
| 2017 Q4 | 4355.78 Billion JPY | 5.16% |
| 2017 Q3 | 4142.03 Billion JPY | 8.95% |
| 2017 Q1 | 3817.01 Billion JPY | -0.18% |
| 2017 Q2 | 3801.81 Billion JPY | -0.4% |
| 2017 FY | 4355.78 Billion JPY | 13.9% |
| 2016 Q2 | 4213.82 Billion JPY | -2.48% |
| 2016 Q4 | 3824.08 Billion JPY | -8.73% |
| 2016 FY | 3824.08 Billion JPY | -10.99% |
| 2016 Q3 | 4189.87 Billion JPY | -0.57% |
| 2016 Q1 | 4320.85 Billion JPY | 0.57% |
| 2015 Q3 | 4653.37 Billion JPY | 1.78% |
| 2015 Q1 | 4437.32 Billion JPY | -2.88% |
| 2015 Q4 | 4296.19 Billion JPY | -7.68% |
| 2015 Q2 | 4571.8 Billion JPY | 3.03% |
| 2015 FY | 4296.19 Billion JPY | -5.97% |
| 2014 Q4 | 4569.14 Billion JPY | 3.24% |
| 2014 FY | 4569.14 Billion JPY | 15.51% |
| 2014 Q3 | 4425.78 Billion JPY | 4.06% |
| 2014 Q2 | 4253.21 Billion JPY | 8.12% |
| 2014 Q1 | 3933.71 Billion JPY | -0.55% |
| 2013 Q4 | 3955.59 Billion JPY | 4.54% |
| 2013 FY | 3955.59 Billion JPY | 10.58% |
| 2013 Q1 | 3467.95 Billion JPY | -3.05% |
| 2013 Q2 | 3482.16 Billion JPY | 0.41% |
| 2013 Q3 | 3783.72 Billion JPY | 8.66% |
| 2012 Q3 | 3421.38 Billion JPY | -2.23% |
| 2012 Q4 | 3577.03 Billion JPY | 4.55% |
| 2012 FY | 3577.03 Billion JPY | 28.37% |
| 2012 Q1 | 2713.56 Billion JPY | -2.61% |
| 2012 Q2 | 3499.28 Billion JPY | 28.96% |
| 2011 Q2 | 2708.66 Billion JPY | 0.91% |
| 2011 Q3 | 2680.06 Billion JPY | -1.06% |
| 2011 Q4 | 2786.4 Billion JPY | 3.97% |
| 2011 FY | 2786.4 Billion JPY | -1.31% |
| 2011 Q1 | 2684.34 Billion JPY | -4.92% |
| 2010 Q4 | 2823.27 Billion JPY | 2.54% |
| 2010 Q3 | 2753.31 Billion JPY | 0.49% |
| 2010 Q2 | 2739.93 Billion JPY | 0.0% |
| 2010 FY | 2823.27 Billion JPY | 2.29% |
| 2009 FY | 2760.18 Billion JPY | -3.13% |
| 2009 Q4 | 2760.18 Billion JPY | 8.05% |
| 2009 Q3 | 2554.65 Billion JPY | 0.0% |
| 2008 FY | 2849.27 Billion JPY | -7.27% |
| 2007 FY | 3072.5 Billion JPY | 0.99% |
| 2006 FY | 3042.29 Billion JPY | 19.52% |
| 2005 FY | 2545.43 Billion JPY | 8.98% |
| 2004 FY | 2335.66 Billion JPY | 13.42% |
| 2003 FY | 2059.36 Billion JPY | 4.79% |
| 2002 FY | 1965.21 Billion JPY | 12.44% |
| 2001 FY | 1747.77 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 3.47 Billion USD | -434989.756% |
| Bausch Health Companies Inc. | 27.35 Billion USD | -55142.384% |
| Catalent, Inc. | 9.75 Billion USD | -154814.303% |
| Emergent BioSolutions Inc. | 1.83 Billion USD | -823312.284% |
| Elanco Animal Health Incorporated | 14.36 Billion USD | -105099.777% |
| Perrigo Company plc | 10.8 Billion USD | -139678.446% |
| Teva Pharmaceutical Industries Limited | 43.47 Billion USD | -34649.631% |
| Zoetis Inc. | 14.28 Billion USD | -105659.429% |